Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 18, 2018 09:05 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China

RUTHERFORD, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
October 16, 2018 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Issues Letter to Shareholders

RUTHERFORD, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
October 08, 2018 07:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics and Cellaria Partner on Precision Medicine Tools

RUTHERFORD, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
September 25, 2018 16:01 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Enters Supply Agreement with Agilent Technologies

RUTHERFORD, N.J., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
September 20, 2018 08:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials

RUTHERFORD, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
September 18, 2018 08:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge

RUTHERFORD, N.J. and JERUSALEM, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through...
August 14, 2018 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates

RUTHERFORD, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
August 07, 2018 16:05 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018

RUTHERFORD, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
July 18, 2018 16:05 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Closes $2.625 million Convertible Note Financing

RUTHERFORD, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
June 12, 2018 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer

RUTHERFORD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...